Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NT5C2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPEL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CNNM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCGF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USMG5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AS3MT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDCD11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BORCS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP17A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CALHM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WBP1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on